Unlocking Insights
in Cardiology

LynxCare's comprehensive data assets* offer fresh insights into Heart Failure and Atrial Fibrillation (AFib), including comorbidity factors and treatment patterns. 

cardio insights

Our granular and quality controlled real-world datasets can unlock invaluable insights into the treatment and prognosis of various cardiac diseases, empowering clinicians to make informed decisions. Through our federated real-world dataset, we can equally help life sciences close evidence gaps throughout the product lifecycle, from development to launch and growth.

Click below and discover our Heart Failure and Atrial Fibrillation (AFib) dataset insights.

Cardiology - unlock insights button HF-1
Cardiology - unlock insights button AFIB-1


Advancing Research

Gamma app_Publications HF-1

Peer-Reviewed Publications

Explore our groundbreaking research in heart failure through our peer-reviewed publications.

Gamma app_Conferences HF-1

Presented Conference Abstracts

Gain valuable insights into heart failure as our experts share their knowledge at scientific conferences.

Reach Out

Building Trust
Quality Control and Data Freshness

Quality Control

We adhere to strict data quality standards to ensure the accuracy and reliability of our data. Our team of experts verifies and validates data from intake, data processing up till analytics, ensuring consistency and completeness throughout the patient pathway. Each statistic needs to be validated by the individual hospital before delivery.

Data Freshness

Our data is updated regularly to ensure we provide insights based on the latest and most accurate information. Leveraging our HL7-based gateway, our datasets remain fresh with a max of 6-months delay.

OMOP CDM Data Warehouse

Our data is stored in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), enabling easy access and integration with other healthcare or research IT solutions. With our well-structured and standardized data storage, our clients can start analyzing the data immediately and efficiently.

narrow data
HF innovation-1

The Future of Cardiac Treatments
How LynxCare Can Help

Personalized Medicine

By providing insights into individual pathways of heart failure patients, our data asset enables clinicians to tailor treatments to specific patient needs, opening up the possibility of personalized medicine (ATTR-CM, Cardiorenal syndrome, SGLT-2 eligibility,...)

Improved Outcomes

By providing insights into the clinical pathway of heart failure patients, our data asset aims to ultimately improve patient outcomes by providing valuable insights for clinicians and researchers (e.g. impact on mortality when admitted via geriatrics).

Continued Innovation

With our comprehensive dataset and world-class expertise, we aim to continue to drive innovation in heart failure treatment and management, ensuring that the latest insights and solutions are available to healthcare providers and researchers.

* LynxCare datasets concern datasets within the LynxCare's European hospital network. The hospitals are the data controllers. No commitment before site approval on RWE request.